Accelerate Diagnostics Inc (AXDX) Return on Investment ROI from the fourth quarter of 2024 to fourth quarter of 2023 and for the year 2024, average high and low, overall ranking from Dec 31 2024 to Dec 31 2023 - CSIMarket
CSIMarket
 


Accelerate Diagnostics Inc   (NASDAQ: AXDX)


Accelerate Diagnostics Inc's ROI from its fourth quarter of 2024 to the fourth quarter of 2023 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Accelerate Diagnostics Inc's ROI in the fourth quarter of 2024?
Accelerate Diagnostics Inc recorded a cumulative net loss of $-50 million during 12 months ending in the fourth quarter of 2024, resulting in a negative return on investment (ROI) of -564.57%.

Within the Healthcare sector 887 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2024 from 3565 to 4460.

Definition and Formula of Return on Investment



Return On Investment (Dec 31 2024)
IV. Quarter
(Sep 30 2024)
III. Quarter
(Jun 30 2024)
II. Quarter
(Mar 31 2024)
I. Quarter
(Dec 31 2023)
IV. Quarter
Y / Y Investment Change TTM - 62.02 % -55.08 % -84.3 % -
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions -3 14 9 15 19
Return On Investment (TTM) - -372.29 % -337.58 % -746.96 % 270848.35 %
AXDX's Overall Ranking # 4460 # 3565 # 3487 # 3191 # 3347
Seq. Investment Change TTM -38.26 % 27.87 % 42.03 % - -
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -50 -53 -38 -59 -62




Return On Investment AXDX's Ranking
Within: No.
Industry # 23
Sector # 888
Overall # 4460

Return On Investment Statistics
High Average Low
-42.03 %
-765.6 %
-24330.9 %
(Dec. 30, 2013)   (Dec 31 2023)







Financial Statements
Accelerate Diagnostics Inc's IV. Quarter Investments $ -3 Millions AXDX's Balance sheet
Accelerate Diagnostics Inc's IV. Quarter Income $ -10 Millions Quarterly AXDX's Income Statement
AXDX's Income by Division See AXDX's Income by Division


AXDX Annual Return On Investment (Dec 31 2024)
2024
(Dec 31 2023)
2023
(Dec 31 2022)
2022
(Dec 31 2021)
2021
(Dec 31 2020)
2020
Total Investments in Millions -3 19 -2 76 86
Y / Y Investment Growth - - - -11.98 % -31.53 %
Net Income in Millions -50 -62 -62 -78 -78
Y / Y Net Income Growth - - - - -
Annual Return On Investment - -318.74 % - -102.1 % -90.46 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Laboratory Analytical Instruments Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
AXDX's Roi Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for AXDX's Competitors
Subscribers only: Roi for Accelerate Diagnostics Inc's Suppliers
Subscribers only: Return On Investment for AXDX's Customers

Other Ratios
AXDX's Roa AXDX's Inventory Turnover Ratio AXDX's Growth Rates AXDX's Dividend Statistics
AXDX's Profitability Ratios AXDX's Asset Turnover Ratio AXDX's Dividend Growth
AXDX's Roe AXDX's Valuation Ratios AXDX's Financial Strength Ratios AXDX's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2024, within Healthcare Sector ROI


Date modified: 2026-09-08T15:11:28+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.